AtaiBeckley Inc. ATAI 深 滬
等待開盤 09-25 09:30:00 美东时间
7.35
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 7.35
- 總市值 27.26亿
- 52周最高 7.45
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 3.265
- 委 比 0.00%
- 總股本 3.71亿
- 歷史最高 22.91
- 量 比 0
- 振 幅 0.00%
- 歷史最低 1.025
- 每 手 1
- 風險率 1.26%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Cantor Fitzgerald Suspends Neutral Rating on AtaiBeckley Inc
Cantor Fitzgerald suspends Neutral rating on AtaiBeckley Inc (NASDAQ:ATAI).
09-22 18:55
Deal Dispatch: Bending Spoons Acquires Miro For $1.35B, Kinetik Up For Sale, LIV Golf Bankruptcy
New On The Block Kinetik Holdings Inc (NYSE:KNTK), the Blackstone-backed Delaware Basin pipeline operator, is weighing strategic alternatives, including a potential sale, Bloomberg reports. Read Also: Apptronik’s Private Market Share Soars 3,600% on Humanoid Robot Hype Updates From The Block Labcorp...
09-12 01:10
AtaiBeckley Says Hart-Scott-Rodino Waiting Period For Merger With Eli Lilly Expired On Aug 28, 2026; UK Competition Authority Has No Further Questions On Merger As Of August 21, 2026
As previously disclosed, AtaiBeckley Inc. (the "Company") entered into an Agreement and Plan of Merger, dated as of July 15, 2026 (the "Merger Agreement"), with Eli Lilly and Company, an Indiana corporation ("Parent") and Albali Acquisition Corporation, a Delaware corporation and indirect wholly own...
09-01 04:42
美股大行评级 | 业绩大超预期！ CoreWeave、超微电脑、Lumentum绩后获多家大行上调目标价
今日重点评级关注：Canaccord Genuity：维持Sagimet Biosciences"买入"评级，目标价从49美元升至56美元；韦德布什：维持Zura Bio"跑赢大市"评级，目标价从15美元升至22美元
08-13 11:44
CoreWeave To Rally Around 95%? Here Are 10 Top Analyst Forecasts For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. HC Wainwright & Co. raised the price target for Belite Bio Inc (NASDAQ:BLTE) from $200 to $214. HC Wainwright ...
08-12 19:53
Deutsche Bank Downgrades AtaiBeckley to Hold, Lowers Price Target to $8
Deutsche Bank analyst David Hoang downgrades AtaiBeckley (NASDAQ:ATAI) from Buy to Hold and lowers the price target from $12 to $8.
08-12 17:57
礼来凭爆款药物上调业绩目标 击退“减肥药降温”质疑
礼来在最新的财报中上调了2026年销售指引，公司的减重药业务在第二季度表现远超预期，缓解了投资者对于“减肥药热潮正在降温”的担忧。 礼来周三表示，公司预计20...
08-05 23:48
Billions Flow Into Next-Generation Depression Treatments as Pharma Innovation Accelerates
Major Depressive Disorder Market Poised for Strong Growth as New Drug Innovations Transform Patient Care NEW YORK, July 21, 2026 /PRNewswire/ -- Market News UpdatesNews Commentary - Globally...
07-21 20:30
美股大行评级 | 伯恩斯坦上调Robinhood目标价从130美元升至160美元；纽约梅隆银行、Datadog、五三银行、旅行者财产险集团获多家机构上调评级
今日重点评级关注：Needham：维持Immuneering"买入"评级，目标价从11美元升至18美元；富瑞：维持塞德斯医疗"买入"评级，目标价从90美元升至100美元
07-21 11:36
